Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | -4.64 | -2.50 | -2.86 | 73.46 | 645.45 |
Employee benefit expenses | -48.56 | - 582.42 | |||
EBIT | -4.64 | -2.50 | -2.86 | 24.89 | 63.03 |
Other financial expenses | -6.85 | -2.99 | |||
Pre-tax profit | -4.64 | -2.50 | -2.86 | 18.05 | 60.04 |
Income taxes | -13.61 | ||||
Net earnings | -4.64 | -2.50 | -2.86 | 18.05 | 46.44 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Intangible assets total | |||||
Tangible assets total | |||||
Investments total | |||||
Long term receivables total | |||||
Inventories total | |||||
Current trade debtors | 111.89 | 139.56 | |||
Prepayments and accrued income | 10.40 | 21.83 | |||
Current other receivables | 159.17 | 184.00 | 256.00 | ||
Short term receivables total | 159.17 | 306.30 | 417.38 | ||
Cash and bank deposits | 164.17 | 161.67 | 33.87 | 545.04 | |
Cash and cash equivalents | 164.17 | 161.67 | 33.87 | 545.04 | |
Balance sheet total (assets) | 164.17 | 161.67 | 159.17 | 340.16 | 962.42 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Share capital | 170.00 | 170.00 | 170.00 | 170.00 | 170.00 |
Retained earnings | -6.19 | -10.83 | -13.33 | -16.19 | 1.85 |
Profit of the financial year | -4.64 | -2.50 | -2.86 | 18.05 | 46.44 |
Shareholders equity total | 159.17 | 156.67 | 153.81 | 171.85 | 218.29 |
Provisions | 4.80 | ||||
Non-current liabilities total | |||||
Current trade creditors | 5.00 | 5.36 | 22.65 | 531.16 | |
Current owed to participating | 94.10 | 84.73 | |||
Short-term deferred tax liabilities | 8.80 | ||||
Other non-interest bearing current liabilities | 5.00 | 51.56 | 114.64 | ||
Current liabilities total | 5.00 | 5.00 | 5.36 | 168.31 | 739.33 |
Balance sheet total (liabilities) | 164.17 | 161.67 | 159.17 | 340.16 | 962.42 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.